UCB Pharma to Use Entelos PhysioLab for Rheumatoid Arthritis Research | GenomeWeb
NEW YORK (GenomeWeb News) - Entelos said today that UCB Pharma will use its PhysioLab biosimulation platform for rheumatoid arthritis research.
The Rheumatoid Arthritis PhysioLab is a predictive computer model that simulates arthritic patients and drug effects.
The company said that researchers use the system to select targets and compounds, find the best doses for patients, and support clinical trial design.
Financial terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.